cbdMD to Acquire Twinlab Brands

cbdMD, Inc. (NYSE: YCBD) has entered into a definitive agreement to acquire operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife, and Alvita Tea. The acquisition is being conducted through an assignment for the benefit of creditors (ABC) proceeding and is subject to court approval and customary closing conditions.

Based on unaudited financial information, the combined previous 12 months of revenue ending June 2026 totals approximately $30 million, representing an increase of about 40% relative to cbdMD’s standalone revenue for the same period, the company reported.

The deal marks cbdMD’s evolution into the broader consumer health market, now including supplements, sports nutrition, longevity, pet health, hemp-derived products, and adjacent categories.

Founded in 1968, Twinlab is well recognized in legacy supplements and sports nutrition, serving 50,000 retail outlets, including Vitamin Shoppe, GNC, and Amazon.

“Twinlab is the kind of brand equity that companies spend decades trying to build,” said Ronan Kennedy, CEO of cbdMD. “The brands, distribution channels, and team are highly complementary to what we already operate, and this transaction gives these brands the stability and support they need for their next chapter.”

He continued: “We believe there is a significant opportunity to build on cbdMD’s revenue growth by applying our marketing, creative, and ecommerce resources to drive brand awareness and expand direct-to-consumer sales, alongside the strong wholesale and retail presence these brands already have. From the fundamentals of nutrition to the frontier of modern wellness, the combined portfolio is a unique offering in consumer wellness.”

Upon closing of the acquisition, the portfolio will expand cbdMD’s reach into additional consumer need states, including daily wellness, active lifestyle, weight management, longevity, recovery, beauty, and functional supplementation. Reserveage brings premium longevity, resveratrol, collagen, and beauty-from-within positioning; Metabolife will bring established weight management brand recognition.

“cbdMD is the right home for these brands,” said Anthony Zolezzi, CEO of Twinlab. “Together, we will bring a uniquely complete wellness portfolio spanning foundational vitamins, minerals, and nutrition through botanicals, beauty, longevity, functional mushrooms, cannabinoids, and the emerging breakthroughs defining where this industry is headed. We believe no other company can serve consumers across more needs, more moments, and more stages of life than we now can together. This combination will pair decades of heritage and category credibility with a modern, marketing-driven platform and the resources to reintroduce these products to a new generation of consumers. It positions the brands, and the people behind them, for a strong future.” 

The agreement follows cbdMD’s earlier acquisition and integration of Bluebird Botanicals and reflects the company’s strategy of building a portfolio of wellness brands.